NIH-funded research R01 grant

Improving newborn screening for metabolic disorders using advanced gene sequencing and metabolomics.

Official title: Multiplex gene sequencing and metabolomics analysis from newborn dried blood spots to improve screening and diagnosis of metabolic disorders.

Funded at Yale University · NIH-10836039 · Data updated 2026-11-12

This study is looking at a new way to quickly and accurately check for metabolic disorders in newborns using advanced testing methods on their blood samples, which could help reduce the need for extra tests and ensure babies get the right treatment faster.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startSeptember 1, 2020
Project endMay 31, 2026
Funding year2024
Award (this year)$478,960
NIH project number5R01HD102537-05
Project IDNIH-10836039 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are newborns who have received a positive screening result for metabolic disorders.

Less likely to help

Patients who are not newborns or those who have not undergone newborn screening may not benefit from this research.

What this research studies

This research focuses on enhancing newborn screening processes by utilizing multiplex gene sequencing and metabolomics analysis on dried blood spots collected from infants at birth. The goal is to develop a more efficient method for confirming positive screening results for metabolic disorders, reducing the need for additional blood and urine tests. By integrating advanced DNA sequencing and mass spectrometry technologies, the study aims to identify true cases of metabolic disorders quickly and accurately, which is crucial for timely treatment in newborns.

Why it matters

Potential benefit: If successful, this research could lead to more accurate and efficient screening for metabolic disorders in newborns, allowing for earlier diagnosis and treatment.

How similar studies have gone: Previous research has shown promise in using advanced sequencing and metabolomics for diagnosing metabolic disorders, indicating that this approach could be effective.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Scharfe, Curt — Yale University
  • Study coordinator: Scharfe, Curt

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.